WEKO3
アイテム
{"_buckets": {"deposit": "f296d03d-90f0-4040-8586-3a039d1e9c7b"}, "_deposit": {"created_by": 1, "id": "70026", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "70026"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00070026", "sets": ["28"]}, "author_link": ["687574", "687570", "687572", "687582", "687568", "687573", "687577", "687581", "687576", "687578", "687579", "687580", "687569", "687567", "687571", "687575"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2010-01-24", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Purpose: We examined the effect of preoperative carbon ion therapy in terms of reducing the rate of local recurrence in patients undergoing resection for adenocarcinoma of the pancreas.\nPatients and Methods: Between July 2000 and December 2002, 22 patients with preoperative pancreas cancer were enrolled into this trial. Median age was 63 years. Carbon ion therapy was given once daily, 4 days a week, for a fixed 16 fractions in 4 weeks. The dose was set to 44.8GyE and escalated to 48.0GyE at 5% increments. \nResults:All patients completed the scheduled treatment course. Three grade3 acute reactions and two grade3 late reactions occurred among 16 of the patients treated with a dose of 48.0GyE. Two grade 3 late reactions of them were estimated to be caused by carbon ion therapy. Of 22 patients, 15(68%) had resection. All tumor specimens pathologically revealed evidence of grade 2 treatment effects with significant fibrosis, hyalinization, and necrosis (Pathological grade2 is defined as a less than 33% active cancer cells.). Remarkable antitumor effects were observed. The overall local control rates were 100% and 87% at 1 year and at 2 years of follow-up respectively. No local failure was observed in any of the 22 enrolled patients.\nConclusion: Carbon ion radiotherapy seems to be a safe and effective modality in the management of resectable pancreatic carcinoma, providing good local control and offering a survival advantage without unacceptable morbidity.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "2010 Gastrointestinal Cancers Symposium", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Shinoto, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "687567", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "687568", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Katou, Hirotoshi"}], "nameIdentifiers": [{"nameIdentifier": "687569", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yasuda, Shigeo"}], "nameIdentifiers": [{"nameIdentifier": "687570", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imada, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "687571", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "687572", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "687573", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saisho, Hiromitsu"}], "nameIdentifiers": [{"nameIdentifier": "687574", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "篠藤 誠", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687575", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山田 滋", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687576", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "加藤 博敏", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687577", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "安田 茂雄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687578", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "今田 浩史", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687579", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687580", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687581", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "税所 宏光", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "687582", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "A Phase I/II Clinical Trial of Carbon-ion Therapy for patients with preoperative pancreas cancer (Protocol 9906, 16fractions/4weeks)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "A Phase I/II Clinical Trial of Carbon-ion Therapy for patients with preoperative pancreas cancer (Protocol 9906, 16fractions/4weeks)"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/70026", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-01-29"}, "publish_date": "2010-01-29", "publish_status": "0", "recid": "70026", "relation": {}, "relation_version_is_last": true, "title": ["A Phase I/II Clinical Trial of Carbon-ion Therapy for patients with preoperative pancreas cancer (Protocol 9906, 16fractions/4weeks)"], "weko_shared_id": -1}
A Phase I/II Clinical Trial of Carbon-ion Therapy for patients with preoperative pancreas cancer (Protocol 9906, 16fractions/4weeks)
https://repo.qst.go.jp/records/70026
https://repo.qst.go.jp/records/70026ba540c42-9a34-4c23-87d7-e9a1fd06dca7
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-01-29 | |||||
タイトル | ||||||
タイトル | A Phase I/II Clinical Trial of Carbon-ion Therapy for patients with preoperative pancreas cancer (Protocol 9906, 16fractions/4weeks) | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Shinoto, Makoto
× Shinoto, Makoto× Yamada, Shigeru× Katou, Hirotoshi× Yasuda, Shigeo× Imada, Hiroshi× Kamada, Tadashi× Tsujii, Hirohiko× Saisho, Hiromitsu× 篠藤 誠× 山田 滋× 加藤 博敏× 安田 茂雄× 今田 浩史× 鎌田 正× 辻井 博彦× 税所 宏光 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose: We examined the effect of preoperative carbon ion therapy in terms of reducing the rate of local recurrence in patients undergoing resection for adenocarcinoma of the pancreas. Patients and Methods: Between July 2000 and December 2002, 22 patients with preoperative pancreas cancer were enrolled into this trial. Median age was 63 years. Carbon ion therapy was given once daily, 4 days a week, for a fixed 16 fractions in 4 weeks. The dose was set to 44.8GyE and escalated to 48.0GyE at 5% increments. Results:All patients completed the scheduled treatment course. Three grade3 acute reactions and two grade3 late reactions occurred among 16 of the patients treated with a dose of 48.0GyE. Two grade 3 late reactions of them were estimated to be caused by carbon ion therapy. Of 22 patients, 15(68%) had resection. All tumor specimens pathologically revealed evidence of grade 2 treatment effects with significant fibrosis, hyalinization, and necrosis (Pathological grade2 is defined as a less than 33% active cancer cells.). Remarkable antitumor effects were observed. The overall local control rates were 100% and 87% at 1 year and at 2 years of follow-up respectively. No local failure was observed in any of the 22 enrolled patients. Conclusion: Carbon ion radiotherapy seems to be a safe and effective modality in the management of resectable pancreatic carcinoma, providing good local control and offering a survival advantage without unacceptable morbidity. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 2010 Gastrointestinal Cancers Symposium | |||||
発表年月日 | ||||||
日付 | 2010-01-24 | |||||
日付タイプ | Issued |